Subsequent experiments focused on the effects of MGIG intervention on the levels of proteins of the TLR4/NF‐κB/Nlrp3 signalling pathway in HFD‐induced hepatic steatosis. The gene discussed is NLRP3; the disease is fatty liver disease.